4//SEC Filing
SAVIENT PHARMACEUTICALS INC 4
Accession 0001230295-07-000786
CIK 0000722104operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 6:05 PM ET
Size
9.4 KB
Accession
0001230295-07-000786
Insider Transaction Report
Form 4
HAYDEN BRIAN J
SVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2007-12-18$5.33/sh−5,000$26,650→ 130,000 totalExercise: $5.33From: 2007-07-05Exp: 2016-07-05→ Common Stock, $.01 par value per share (5,000 underlying) - Sale
Common Stock, $.01 par value per share
2007-12-18$20.09/sh−5,000$100,440→ 31,910 total - Exercise/Conversion
Common Stock, $.01 par value per share
2007-12-18$5.33/sh+5,000$26,650→ 36,910 total
Footnotes (2)
- [F1]This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934.
- [F2]Represents the average sale price. The highest price at which shares were sold was $20.22 and the lowest price at which shares were sold was $20.00.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 6:05 PM ET
- Size
- 9.4 KB